Skip Nav Destination
Issues
1 June 1999
ISSN 1078-0432
EISSN 1557-3265
Advances in Brief
Reduction of BRCA1 Protein Expression in Japanese Sporadic Breast Carcinomas and Its Frequent Loss in BRCA1-associated Cases
Kiyotsugu Yoshikawa; Kazuo Honda; Takashi Inamoto; Hisashi Shinohara; Akira Yamauchi; Kenji Suga; Takazo Okuyama; Toshihide Shimada; Hiroshi Kodama; Shinzaburo Noguchi; Adi F. Gazdar; Yoshio Yamaoka; Rei Takahashi
Clinical Trials
A Phase I Study of Continuous Infusion Doxorubicin and Paclitaxel Chemotherapy with Granulocyte Colony-Stimulating Factor for Relapsed Epithelial Ovarian Cancer1
Linda R. Duska; Richard Penson; Jeffrey G. Supko; Dianne M. Finkelstein; Thomas Makastorsis; Joan Gallagher; Karen Borden; Annekathryn Goodman; Arlan F. Fuller; Najmosama Nikrui; Michael V. Seiden
Rhenium-186-labeled Hydroxyethylidene Diphosphonate Dosimetry and Dosing Guidelines for the Palliation of Skeletal Metastases from Androgen-independent Prostate Cancer1
Martin C. Graham; Howard I. Scher; Gen-Bao Liu; Samuel D-J. Yeh; Tracy Curley; Farhad Daghighian; Stanley J. Goldsmith; Steven M. Larson
A Phase I Study of Active Immunotherapy with Carcinoembryonic Antigen Peptide (CAP-1)-pulsed, Autologous Human Cultured Dendritic Cells in Patients with Metastatic Malignancies Expressing Carcinoembryonic Antigen1
Michael A. Morse; Yuping Deng; Doris Coleman; Shelley Hull; Eva Kitrell-Fisher; Smita Nair; Jeffrey Schlom; Mary-Ellen Ryback; H. Kim Lyerly
Phase I Study of Transforming Growth Factor-β3 Mouthwashes for Prevention of Chemotherapy-induced Mucositis
A. N. Machteld Wymenga; Winette T. A. van der Graaf; Lieuwe S. Hofstra; Fred K. L. Spijkervet; Wim Timens; Hetty Timmer-Bosscha; Wim J. Sluiter; A. H. J. A. W. van Buuren; Nanno H. Mulder; Elisabeth G. E. de Vries
Molecular Oncology, Markers, Clinical Correlates
Expression of Proinflammatory and Proangiogenic Cytokines in Patients with Head and Neck Cancer1
Zhong Chen; Pramit S. Malhotra; Giovana R. Thomas; Frank G. Ondrey; Dianne C. Duffey; Conrad W. Smith; Ileana Enamorado; Ning T. Yeh; Glenn S. Kroog; Susan Rudy; Linda McCullagh; Shaker Mousa; Matha Quezado; Laurie L. Herscher; Carter Van Waes
Messenger RNA Determination of Estrogen Receptor, Progesterone Receptor, pS2, and Plasminogen Activator Inhibitor-1 by Competitive Reverse Transcription-Polymerase Chain Reaction in Human Breast Cancer1
Dan Tong; Christian Schneeberger; Klaus Czerwenka; Rita K. Schmutzler; Paul Speiser; Elisabeth Kucera; Nicole Concin; Ernst Kubista; Sepp Leodolter; Robert Zeillinger
Experimental Therapeutics, Preclinical Pharmacology
Ionizing Radiation Improves Survival in Mice Bearing Intracranial High-Grade Gliomas Injected with Genetically Modified Herpes Simplex Virus1
Jeffrey D. Bradley; Yasushi Kataoka; Sunil Advani; Su Mi Chung; Ramin B. Arani; G. Yancey Gillespie; Richard J. Whitley; James M. Markert; Bernard Roizman; Ralph R. Weichselbaum
Use of Carrier Cells to Deliver a Replication-selective Herpes Simplex Virus-1 Mutant for the Intraperitoneal Therapy of Epithelial Ovarian Cancer1
George Coukos; Antonis Makrigiannakis; Eugene H. Kang; David Caparelli; Ivor Benjamin; Larry R. Kaiser; Stephen C. Rubin; Steven M. Albelda; Katherine L. Molnar-Kimber
Cancer Biology, Immunology, Cytokines
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.